Skip to content
healthcare.dev
Get a free key

Equate ClearLAX

NDC 79903-114, Polyethylene Glycol 3350, powder, for solution, from WALMART INC..

Product NDC
79903-114
Status
Listed
Labeler
WALMART INC.
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA090685
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/79903-114 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
79903-114-1479903011414238 g in 1 BOTTLE (79903-114-14)
79903-114-3079903011430510 g in 1 BOTTLE (79903-114-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 79903-114 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/79903-114 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 79903-114. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.